| Full Name | Diane Tear |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 310 Douglas Dr, Sandusky, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104240613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3546 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diane Tear, 310 Douglas Dr, Sandusky, OH 44870-5744 Ph: () - | Diane Tear, 310 Douglas Dr, Sandusky, OH 44870-5744 Ph: (419) 625-4352 |
News Archive
Australian researchers have developed the country's first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.
RegeneRx Biopharmaceuticals, Inc. announced today that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company's drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease. The double-blind, placebo-controlled, investigator-sponsored trial is expected to enroll a total of 20 patients over the next several months, with data reported later in 2011. RGN-259 is a sterile, preservative-free topical eye drop formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4.
The coronavirus pandemic — and the economic fallout that has come with it — boosted health insurance enrollment counselor Mark Van Arnam's workload. But he wants to be even busier.
Researchers at the Center for the Ecology of Infectious Diseases and the College of Public Health at the University of Georgia revealed alternative ways to control the pandemic spread without resorting to these measures.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that it has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide licenses for technology and intellectual property for novel DNA vaccines against pandemic influenza, Chikungunya, and foot-and-mouth disease.
› Verified 1 days ago
Alaina A Bier, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 924 Ontario St, Sandusky, OH 44870 Phone: 419-984-1250 | |
Mrs. Ashley N Lawlor, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1210 E Bogart Rd, Sandusky, OH 44870 Phone: 419-681-2852 | |
Lisa Butler, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2500 W Strub Rd Ste 150, Sandusky, OH 44870 Phone: 419-626-4162 Fax: 419-626-2071 | |
Amanda Notestine, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 167 E Washington Row, Sandusky, OH 44870 Phone: 419-217-7635 | |
Jennifer Pelham, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 318 Columbus Ave, Sandusky, OH 44870 Phone: 419-626-3961 | |
Mrs. Janet Ann Rhode, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 318 Columbus Ave, Sandusky, OH 44870 Phone: 419-627-3993 |